Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Contamination In Common OTC Antacid Adds To FDA's API Impurity Concerns

Sep 15 2019

• By Eileen Francis

Medical engineering concept_227959225_1200.jpg

Related Content

US FDA Scrutizes Process Risks After Finding Nitrosamines In ARBs

Aug 29 2019

Sanofi's Consumer Health Q2 Results Ride Emerging Markets Boost

Jul 31 2018

Perrigo Feeds OTC Brand Play With Prevacid As GSK Thins Consumer Lineup

Sep 05 2019

US FDA Scrutinizes Process Risks After Nitrosamines Found In ARBs

Aug 30 2019

Related Companies

Sanofi

Additional Topics

United States Advertising, Marketing & Sales Approvals Commercial Companies Compliance Drug Approval Standards Enforcement FDA Ingredients Manufacturing OTC Drugs Policy Recalls Regulation Safety Consumer Gastrointestinal

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window